BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22314528)

  • 1. MK-4815, a potential new oral agent for treatment of malaria.
    Powles MA; Allocco J; Yeung L; Nare B; Liberator P; Schmatz D
    Antimicrob Agents Chemother; 2012 May; 56(5):2414-9. PubMed ID: 22314528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel 4-aminoquinoline analogs highly active against the blood and sexual stages of Plasmodium in vivo and in vitro.
    Sáenz FE; Mutka T; Udenze K; Oduola AM; Kyle DE
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4685-92. PubMed ID: 22710117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin for malaria therapy.
    Reddy RC; Vatsala PG; Keshamouni VG; Padmanaban G; Rangarajan PN
    Biochem Biophys Res Commun; 2005 Jan; 326(2):472-4. PubMed ID: 15582601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trisubstituted Pyrimidines as Efficacious and Fast-Acting Antimalarials.
    Norcross NR; Baragaña B; Wilson C; Hallyburton I; Osuna-Cabello M; Norval S; Riley J; Stojanovski L; Simeons FR; Porzelle A; Grimaldi R; Wittlin S; Duffy S; Avery VM; Meister S; Sanz L; Jiménez-Díaz B; Angulo-Barturen I; Ferrer S; Martínez MS; Gamo FJ; Frearson JA; Gray DW; Fairlamb AH; Winzeler EA; Waterson D; Campbell SF; Willis P; Read KD; Gilbert IH
    J Med Chem; 2016 Jul; 59(13):6101-20. PubMed ID: 27314305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplasmodial efficacy of
    Satish PVV; Kumari DS; Sunita K
    J Vector Borne Dis; 2017; 54(3):215-225. PubMed ID: 29097636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective activity of biflavanones from Garcinia kola against Plasmodium infection.
    Konziase B
    J Ethnopharmacol; 2015 Aug; 172():214-8. PubMed ID: 26129936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimalarial efficacy of Pongamia pinnata (L) Pierre against Plasmodium falciparum (3D7 strain) and Plasmodium berghei (ANKA).
    Satish PVV; Sunita K
    BMC Complement Altern Med; 2017 Sep; 17(1):458. PubMed ID: 28893216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery.
    Meister S; Plouffe DM; Kuhen KL; Bonamy GM; Wu T; Barnes SW; Bopp SE; Borboa R; Bright AT; Che J; Cohen S; Dharia NV; Gagaring K; Gettayacamin M; Gordon P; Groessl T; Kato N; Lee MC; McNamara CW; Fidock DA; Nagle A; Nam TG; Richmond W; Roland J; Rottmann M; Zhou B; Froissard P; Glynne RJ; Mazier D; Sattabongkot J; Schultz PG; Tuntland T; Walker JR; Zhou Y; Chatterjee A; Diagana TT; Winzeler EA
    Science; 2011 Dec; 334(6061):1372-7. PubMed ID: 22096101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New quinoline derivatives demonstrate a promising antimalarial activity against Plasmodium falciparum in vitro and Plasmodium berghei in vivo.
    Soares RR; da Silva JM; Carlos BC; da Fonseca CC; de Souza LS; Lopes FV; de Paula Dias RM; Moreira PO; Abramo C; Viana GH; de Pila Varotti F; da Silva AD; Scopel KK
    Bioorg Med Chem Lett; 2015 Jun; 25(11):2308-13. PubMed ID: 25920564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical evaluation of the antifolate QN254, 5-chloro- N'6'-(2,5-dimethoxy-benzyl)-quinazoline-2,4,6-triamine, as an antimalarial drug candidate.
    Nzila A; Rottmann M; Chitnumsub P; Kiara SM; Kamchonwongpaisan S; Maneeruttanarungroj C; Taweechai S; Yeung BK; Goh A; Lakshminarayana SB; Zou B; Wong J; Ma NL; Weaver M; Keller TH; Dartois V; Wittlin S; Brun R; Yuthavong Y; Diagana TT
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2603-10. PubMed ID: 20350951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of pyridyl thiosemicarbazones as highly potent agents for the treatment of malaria after oral administration.
    Parkinson CJ; Birrell GW; Chavchich M; Mackenzie D; Haynes RK; de Kock C; Richardson DR; Edstein MD
    J Antimicrob Chemother; 2019 Oct; 74(10):2965-2973. PubMed ID: 31325302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo activity of solithromycin (CEM-101) against Plasmodium species.
    Wittlin S; Ekland E; Craft JC; Lotharius J; Bathurst I; Fidock DA; Fernandes P
    Antimicrob Agents Chemother; 2012 Feb; 56(2):703-7. PubMed ID: 22083475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimalarial efficacy of hydroxyethylapoquinine (SN-119) and its derivatives.
    Sanders NG; Meyers DJ; Sullivan DJ
    Antimicrob Agents Chemother; 2014; 58(2):820-7. PubMed ID: 24247136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo anti-malarial activity of novel harmine-analog heat shock protein 90 inhibitors: a possible partner for artemisinin.
    Bayih AG; Folefoc A; Mohon AN; Eagon S; Anderson M; Pillai DR
    Malar J; 2016 Dec; 15(1):579. PubMed ID: 27903279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimalarial and antiplasmodial activity of husk extract and fractions of Zea mays.
    Okokon JE; Antia BS; Mohanakrishnan D; Sahal D
    Pharm Biol; 2017 Dec; 55(1):1394-1400. PubMed ID: 28320254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a new chemical class of antimalarials.
    Brunner R; Aissaoui H; Boss C; Bozdech Z; Brun R; Corminboeuf O; Delahaye S; Fischli C; Heidmann B; Kaiser M; Kamber J; Meyer S; Papastogiannidis P; Siegrist R; Voss T; Welford R; Wittlin S; Binkert C
    J Infect Dis; 2012 Sep; 206(5):735-43. PubMed ID: 22732921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JPC-2997, a new aminomethylphenol with high in vitro and in vivo antimalarial activities against blood stages of Plasmodium.
    Birrell GW; Chavchich M; Ager AL; Shieh HM; Heffernan GD; Zhao W; Krasucki PE; Saionz KW; Terpinski J; Schiehser GA; Jacobus LR; Shanks GD; Jacobus DP; Edstein MD
    Antimicrob Agents Chemother; 2015 Jan; 59(1):170-7. PubMed ID: 25331702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo antimalarial activities of T-2307, a novel arylamidine.
    Kimura A; Nishikawa H; Nomura N; Mitsuyama J; Fukumoto S; Inoue N; Kawazu S
    Antimicrob Agents Chemother; 2012 Apr; 56(4):2191-3. PubMed ID: 22252809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy Modeling.
    Le Bihan A; de Kanter R; Angulo-Barturen I; Binkert C; Boss C; Brun R; Brunner R; Buchmann S; Burrows J; Dechering KJ; Delves M; Ewerling S; Ferrer S; Fischli C; Gamo-Benito FJ; Gnädig NF; Heidmann B; Jiménez-Díaz MB; Leroy D; Martínez MS; Meyer S; Moehrle JJ; Ng CL; Noviyanti R; Ruecker A; Sanz LM; Sauerwein RW; Scheurer C; Schleiferboeck S; Sinden R; Snyder C; Straimer J; Wirjanata G; Marfurt J; Price RN; Weller T; Fischli W; Fidock DA; Clozel M; Wittlin S
    PLoS Med; 2016 Oct; 13(10):e1002138. PubMed ID: 27701420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimalarial activity of Floxacrine (HOE 991) I. Studies on blood schizontocidal action of Floxacrine against Plasmodium berghei, P. vinckei and P. cynomolgi.
    Raether W; Fink E
    Ann Trop Med Parasitol; 1979 Dec; 73(6):505-26. PubMed ID: 120142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.